Suchergebnisse - "Duricova, Dana"

PubPharm (97)

1

Tofacitinib in Pregnancy : Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Mitrova, K. | Julsgaard, M. | Augustijns, P. | +9

2

Subcutaneous Infliximab in Refractory Crohn's Disease Patients : A Possible Biobetter?

enthalten in: Crohn's & colitis 360 | 2023

von Cerna, K. | Duricova, D. | Lukas, M. | +11

3

The cost of inflammatory bowel disease in high-income settings : a Lancet Gastroenterology & Hepatology Commission

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Burisch, J. | Zhao, M. | Odes, S. | +30

CommentIn: Lancet Gastroenterol Hepatol. 2023 May;8(5):396-398. - PMID 36871567

4

Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome : A Prospective Multicentre Study

enthalten in: Journal of Crohn's & colitis | 2022

von Mitrova, K. | Pipek, B. | Bortlik, M. | +17

5

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy : Prospective Single-Tertiary Study

enthalten in: Inflammatory bowel diseases | 2022

von Cerna, K. | Duricova, D. | Lukas, M. | +9

6

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients

enthalten in: Journal of Crohn's & colitis | 2022

von Cerna, K. | Duricova, D. | Hindos, M. | +9

7

Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients : An International Web-based Survey

enthalten in: Journal of Crohn's & colitis | 2022

von Ellul, P. | Revés, J. | Abreu, B. | +24

8

Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease

enthalten in: Gastroenterology | 2021

von Pariente, B. | Torres, J. | Burisch, J. | +23

CommentIn: Gastroenterology. 2021 Sep;161(3):800-802. - PMID 34175282

9

Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial

enthalten in: Journal of clinical medicine | 2021

von Březina, J. | Bajer, L. | Wohl, P. | +12

10

Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease : a prospective multicentre study

enthalten in: Therapeutic advances in gastroenterology | 2021

von Mitrova, K. | Pipek, B. | Bortlik, M. | +16

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]